Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Dementia: a looming threat for women with hypertensive disorders of pregnancy?

Abe M, Arima H.

Hypertens Res. 2024 Apr;47(4):975-977. doi: 10.1038/s41440-024-01588-9. Epub 2024 Feb 9.

Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer's disease

Choi BJ, Park MH, Jin HK, Bae JS.

Exp Mol Med. 2024 Feb;56(2):301-310. doi: 10.1038/s12276-024-01176-4. Epub 2024 Feb 9.

The Role of Diet and Gut Microbiota in Alzheimer's Disease

Dissanayaka DMS, Jayasena V, Rainey-Smith SR, Martins RN, Fernando WMADB.

Nutrients. 2024 Jan 31;16(3):412. doi: 10.3390/nu16030412.

Protein Misfolding in Pregnancy: Current Insights, Potential Mechanisms, and Implications for the Pathogenesis of Preeclampsia

Medegan Fagla B, Buhimschi IA.

Molecules. 2024 Jan 26;29(3):610. doi: 10.3390/molecules29030610.

Presenilin: A Multi-Functional Molecule in the Pathogenesis of Alzheimer's Disease and Other Neurodegenerative Diseases

Sun Y, Islam S, Michikawa M, Zou K.

Int J Mol Sci. 2024 Feb 1;25(3):1757. doi: 10.3390/ijms25031757.

Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies

Alkhalifa AE, Al-Ghraiybah NF, Kaddoumi A.

Int J Mol Sci. 2024 Feb 5;25(3):1914. doi: 10.3390/ijms25031914.

Aging-Related Protein Alterations in the Brain

Syed RA, Hayat M, Qaiser H, Uzair M, Al-Regaiey K, Khallaf R, Kaleem I, Bashir S.

J Alzheimers Dis. 2024;99(s1):S5-S22. doi: 10.3233/JAD-230801.

Lucidity in the Deeply Forgetful: A Scoping Review

Ross JP, Post SG, Scheinfeld L.

J Alzheimers Dis. 2024;98(1):3-11. doi: 10.3233/JAD-231396.

Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer's disease

He J, Tam KY.

Drug Discov Today. 2024 Apr;29(4):103914. doi: 10.1016/j.drudis.2024.103914. Epub 2024 Feb 8.

The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons

Sharma M, Pal P, Gupta SK.

Brain Res. 2024 Apr 15;1829:148797. doi: 10.1016/j.brainres.2024.148797. Epub 2024 Feb 10.

Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial

Singh S, Cocoros NM, Li X, Mazor KM, Antonelli MT, Parlett L, Paullin M, Harkins TP, Zhou Y, Rochon PA, Platt R, Dashevsky I, Massino C, Saphirak C, Crawford SL, Gurwitz JH.

PLoS One. 2024 Feb 12;19(2):e0297562. doi: 10.1371/journal.pone.0297562. eCollection 2024.

The role of microglia heterogeneity in synaptic plasticity and brain disorders: Will sequencing shed light on the discovery of new therapeutic targets?

You Y, Chen Z, Hu WW.

Pharmacol Ther. 2024 Mar;255:108606. doi: 10.1016/j.pharmthera.2024.108606. Epub 2024 Feb 10.

The contribution of β-amyloid, Tau and α-synuclein to blood-brain barrier damage in neurodegenerative disorders

Wu YC, Bogale TA, Koistinaho J, Pizzi M, Rolova T, Bellucci A.

Acta Neuropathol. 2024 Feb 12;147(1):39. doi: 10.1007/s00401-024-02696-z.

Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein

Alhadidy MM, Kanaan NM.

Biochem Soc Trans. 2024 Feb 28;52(1):301-318. doi: 10.1042/BST20230596.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias